The developers of three popular health-related mobile apps have agreed to settle allegations that they potentially harmed consumers by making misleading claims about the accuracy of the technologies’ results, the New York Attorney General’s Office announced Thursday.
As part of the agreement, the app developers and the companies agreed “to amend deceptive statements about their apps and modify their privacy policies to better protect consumers, while also making clear that their apps are not medical devices and are not approved by the U.S. Food and Drug Administration,” according to the office of New York Attorney General Eric Schneiderman. The app makers also agreed to pay $30,000 in combined penalties.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
